Intracranial germinoma research hub

MonoGerm: A trial to test if using one chemotherapy drug is as good as using three chemotherapy drugs before radiotherapy for patients with germinoma brain tumours

The MonoGerm trial is testing if one chemotherapy drug works as well as three for a type of brain tumour called germinoma. We want to see if one drug has fewer side effects and improves quality of life before standard radiotherapy.